![]() ![]() It is not known how many applications will be received.ġ1) What is the initial period of performance?Īn award will be made upon selection and award negotiation. We suggest that organizations work with their professional networks to identify potential partners.ġ0) How many firms do you anticipate are replying to these opportunities? The NIH does not connect organizations to respond to the PMI Cohort Program funding opportunities. See the “Eligible Applicants” section of the funding opportunity.ĩ) Does the NIH have a forum for large and small organizations to discover one another? Yes, partnering is allowed among eligible applicants. Please see the Eligibility Information row in the table at the front of OT-PM-16-001.Ĩ) Is partnering permitted among eligible applicants? Yes, nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education), are eligible to apply. All eligible entities are welcome to apply.ħ) Can an entity with a tax exempt status other than 501(c)(3) apply? Applicants are encouraged to review the eligibility criteria outlined in the OT opportunities. The submission requirements are outlined within the particular funding opportunity, each of which can be found here and reference the application process.Ħ) Does the NIH have an individual/group identified for the OT awards? The total application is not to exceed 25 pages.ĥ) Can the NIH provide guidance on application submission requirements? Late applications will not be considered.Ĥ) Can we include appendices to supplement the 25-page proposal? The application due dates are non-negotiable. You may apply to both OT award ( OT-PM-16-001 OT-PM-16-002) and grant solicitations ( RFA-PM-16-001 RFA-PM-16-002 RFA-PM-16-003 RFA-PM-16-004).ģ) Are application due dates firm or is there a possibility that these dates may be extended? Typical government procurement and grant laws, regulations and policies do not apply to OT awards.Ģ) Can I apply to both the OT award and grant solicitations? ![]() Other Transaction Authority is limited to those government agencies and operational divisions with appropriated authority, and is a funding mechanism which targets non-traditional sources and allows a high degree of flexibility in how the agreement is awarded. 1) Can the NIH please provide more clarity on the funding instrument that is noted in the OT award solicitations? ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |